Bloomberg TV(@BloombergTV):Moderna CEO Stéphane Bancel calls the company’s cancer vaccine study with Merck a “landmark,” pointing to a 42% improvement compared with Keytruda alone. Bancel says Moderna is now focused on filing the drug with the FDA and believes it could be approved next year

Bloomberg TV

@BloombergTV

Breaking news. In-depth analysis. Market-moving scoops. Exclusive interviews. Sign up for the Wall Street Week newsletter:

加入 April 2009

563 正在關注 893.1K 粉絲

Bloomberg TV@BloombergTV

2026.10.26 19:28

Moderna CEO Stéphane Bancel calls the company’s cancer vaccine study with Merck a “landmark,” pointing to a 42% improvement compared with Keytruda alone. Bancel says Moderna is now focused on filing the drug with the FDA and believes it could be approved next year